Nearly 30% of women diagnosed with early-stage breast cancer develop metastatic disease, which is when the cancer can come back in another part of the body months or years after the original diagnosis. Today, Metastatic Breast Cancer Awareness Day, serves as a crucial reminder of why our Menarini Stemline team remains driven to find new options for the individuals living with metastatic breast cancer. #BreastCancerAwarenessMonth
MENARINI Group
Fabbricazione di prodotti farmaceutici
Firenze, Italy 344.696 follower
Chi siamo
The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group
- Sito Web
-
https://www.menarini.com
Link esterno per MENARINI Group
- Settore
- Fabbricazione di prodotti farmaceutici
- Dimensioni dell’azienda
- Oltre 10.001 dipendenti
- Sede principale
- Firenze, Italy
- Tipo
- Società privata non quotata
- Settori di competenza
- ALLERGOLOGY, ANDROLOGY, ANTINFECTIVE AREA, CARDIOVASCULAR AREAS, GASTROINTESTINAL DISORDERS, GYNECOLOGY AND WOMEN'S WELLNESS, PAIN, TRAUMA AND HEADACHES, RESPIRATORY AREA, REUMATOLOGY, FLU, COUGHS AND COLDS, DERMATOLOGY AND PERSONAL CARE, FOOD SUPPLEMENTS, ONCOLOGY e DIAGNOSTICS
Località
-
Principale
Via dei Sette Santi 1/3
Firenze, Italy 50131, IT
-
Dipendenti presso MENARINI Group
Aggiornamenti
-
We are delighted to announce the continued success of our academic and scientific collaboration with the Università Cattolica del Sacro Cuore's Master in International Marketing Management - MIMM program. This year marked our third year of partnership, where we jointly contribute to the development of future leaders in business management. This collaboration is a key component of Menarini's commitment towards new generations. Dr. Steven Januar Kusmanto, MBA (Global Director, Digital & Customer Engagement), delivered a comprehensive four-hour guest lecture session as part of this initiative. Through such professional sharing sessions, we aim to bridge the gap between academia and real-world experience, providing MIMM students with valuable industry insights and exposure to practical work environments. This year's session, titled "From Strategy to Success: Decoding Winning Marketing Principles," was moderated by Prof. Tzannis Alessandra (Program Manager MIMM) and received positive feedback from over 32 participating students. We are proud to continue this valuable partnership with Cattolica University and contribute to the educational journey of their talented MIMM students. #Menarini #WeAreMenarini
-
Today, October 2nd, is World MRSA Awareness Day! We are taking this opportunity to raise awareness about methicillin-resistant Staphylococcus aureus (MRSA), a type of bacteria that's resistant to many antibiotics. Swipe through our carousel to learn about MRSA , how it spreads, and what you can do to prevent it from spreading. #Menarini #MRSA #MRSAAwarenessDay #AntibioticResistance
-
Today marks the start of Breast Cancer Awareness Month. At Menarini Stemline, we are committed to improving the outcomes for those impacted by breast cancer, the most commonly diagnosed cancer in women worldwide. #BreastCancerAwarenessMonth
-
#RareCancer Day
Rare cancer diagnoses account for about 25% of all cancer diagnoses. This #RareCancer Day learn more about BPDCN, a rare, aggressive hematologic malignancy: BPDCNinfo.com
-
On September 29th, we celebrate World Heart Day, an occasion to emphasize the critical importance of cardiovascular health. It's crucial to remember that an estimated 80% of cardiovascular diseases, encompassing heart disease and stroke, can be prevented. This year, the World Heart Federation's global campaign centers on the theme "Use Heart for Action," aiming to encourage the development of national cardiovascular health plans. Menarini Group with over 30 years of commitment in improving cardiovascular disease as a leader in cardiovascular care, is proud to be part of this global mission. #WorldHeartDay #HeartHealth #CardiovascularHealth #MenariniGroup #Menarini
-
Siete pronte a fare la differenza? Domani, dalle 9:30 alle 16:30, vi invitiamo al nostro stand virtuale in occasione dell'evento #StemGirls Un'intera giornata dedicata alle donne del mondo STEM, con un intervento speciale di Simona Scartoni, Global Biostatistics and Data Management Director. Accedi al link per registrarti: jobmeeting.it/stemgirls #WomenInStem #University #WeAreMenarini
-
Asthma is a chronic lung disease that can affect people of all ages, caused by inflammation and muscle tightening around the airways, making breathing more difficult. Typical symptoms can include coughing, shortness of breath, and chest tightness. Other common symptoms include wheezing and a whistling sound in the chest. Discover in our Blog what is an asthma attack and the significant impact on a person’s quality of life 👉 https://lnkd.in/d9yg4Phq #Menarini #Asthma #MenariniBlog
-
Menarini will be present at the 60th Annual Meeting of the European Association for the Study of Diabetes, EASD 2024 from September 9th to 13th in Madrid, Spain. Visit us at booth E.09 With an exceptional scientific programme that extensively covers scientific research, current treatments, technologies and care, the EASD Annual Meeting provides the perfect setting to exchange ideas and network with peers from all over the world, connecting the global diabetes community, sharing groundbreaking diabetes science and research, and offering educational opportunities. We look forward to seeing you in Madrid #Menarinigroup #EASD2024 #MenariniCardiometabolics #T2D #Diabetes #Cardiometabolicdiseases
-
We’re excited to announce Menarini Group's presence in Vienna at the European Respiratory Society (ERS) Congress 2024 from 7th to 11th September. Discover the latest innovations in respiratory care, cutting-edge AI solutions and sustainable practices. Meet the experts and engage in thought-provoking discussions. Visit our booth at B5.01 to learn more! See you there! Join us in Vienna: #ERS2024 #MesseWien #RespiratoryHealth #Innovation #Sustainability #AI #MenariniGroup